Telomir Pharmaceuticals, Inc. · NASDAQ:TELO
Aminov Erez reported 1 trade in Telomir Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 22, 2026 · Filed Apr 24, 2026
On Apr 22, 2026, Aminov Erez (Director, CEO and Chairman) reported 1 trade in Telomir Pharmaceuticals, Inc. shares at US$1.37 for US$10M, leaving 7,319,710 shares. Filed Apr 24, 2026 (Form 4).
- Shares
- 7,319,710 shares
- Price
- US$1.37
- Value
- US$10M
- Holding after
- 7,319,710 shares
- Trading plan
- No
- Role
- Director, CEO and Chairman
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 22, 2026 | Common Stock | Other | 7,319,710 | US$1.37 | 7,319,710 | Direct |
Source
Related
- Telomir Pharmaceuticals, Inc.
- Aminov Erez
- Telomir Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity · Aug 14, 2026
- Schedule 13G/A · John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity · Feb 12, 2026
- Schedule 13G · John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity · Sep 18, 2025